Literature DB >> 984193

Gastric A-cell function in normal dogs.

L Muñoz-Barragan, E Blazquez, G S Patton, R E Dobbs, R H Unger.   

Abstract

Glucagon release from the gastric fundus and pancreas were compared in normal dogs by measuring glucagon in plasma from a major gastroepiploic vein, the superior pancreaticoduodenal vein, and the inferior vena cava. In 32 dogs in the basal state, gastric vein glucagon averaged 97 +/- 40 pg/ml, not significantly different from the 93 +/- 41 pg/ml level in the vena cava. Pancreaticoduodenal vein glucagon averaged 250 +/- 32 pg/ml (P less than 0.001). Intravenous arginine infused in four dogs caused a rise in mean gastric vein glucagon to 210 +/- 33 pg/ml within 3 min, and glucagon remained between 53 and 98 pg/ml above the vena caval level thereafter. In the gastric vein, the rise in glucagon was significantly greater than in the vena cava at 3, 5, and 10 min (P less than 0.05), but was far less than in the pancreaticoduodenal vein where glucagon rose to 1,295 +/- 379 pg/ml at 1.5 min. Evidence of modest gastric glucagon release was observed after the intragastric instillation of arginine, but not during insulin or phloridzin-induced hypoglycemia. It was concluded that in normal dogs under the circumstances studied, the gastric fundus is not a major source of circulating glucagon.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 984193     DOI: 10.1152/ajplegacy.1976.231.4.1057

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  11 in total

Review 1.  Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover.

Authors:  Roger H Unger; Alan D Cherrington
Journal:  J Clin Invest       Date:  2012-01-03       Impact factor: 14.808

2.  Vagal stimulation and its role in eliciting gastrin but not glucagon release from the isolated perfused dog stomach.

Authors:  P J Lefebvre; A S Luyckx; A H Brassinne
Journal:  Gut       Date:  1978-03       Impact factor: 23.059

3.  Factors controlling gastric-glucagon release.

Authors:  P J Lefèbvre; A S Luyckx
Journal:  J Clin Invest       Date:  1977-04       Impact factor: 14.808

4.  Lack of gastrointestinal glucagon response to hypoglycaemia in depancreatized dogs.

Authors:  T Matsuyama; R Tanaka; K Shima; K Nonaka; S Tarui
Journal:  Diabetologia       Date:  1978-12       Impact factor: 10.122

5.  Extrapancreatic glucagon and glucagonlike immunoreactivity in depancreatized dogs. A quantitative assessment of secretion rates and anatomical delineation of sources.

Authors:  W A Muller; L Girardier; J Seydoux; M Berger; A E Renold; M Vranic
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

6.  The role of glucagon deficiency in the Houssay phenomenon of dogs.

Authors:  H Nakabayashi; R E Dobbs; R H Unger
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

7.  Plasma pancreatic glucagon response to blood glucose in experimental pancreatolithiasis in dogs.

Authors:  N Okumura; T Hayakawa; A Sakakibara; A Noda; T Kondo
Journal:  Diabetologia       Date:  1983-12       Impact factor: 10.122

8.  The role of gastric glucagon immunoreactivity in pancreatectomized dogs.

Authors:  S Ikei; K Mori; Y Sakamoto; J Ishii; O Watanabe; M Inoue; M Akagi
Journal:  Jpn J Surg       Date:  1980-09

9.  Effect of stimulation of endogenous glucagon secretion by amino acid administration on canine hepatic bile flow.

Authors:  D L Kaminski; Y Deshpande; M C Beinfeld
Journal:  Dig Dis Sci       Date:  1987-04       Impact factor: 3.199

10.  Evidence of glucagon biosynthesis involving protein intermediates in rat salivary glands.

Authors:  A Perez Castillo; E Blazquez
Journal:  Diabetologia       Date:  1984-10       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.